Author:
Herrera L,Yarbrough S,Ghetie V,Aquino D B,Vitetta E S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference22 articles.
1. Brenner MK, Pinkel D . Cure of leukemia. Semin Hematol 1999; 4: 73–83.
2. Lilleyman J . Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years. Pediat Drugs 1999; 1: 197–209.
3. Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V, Ramilo O, Thorpe PE, Uhr JW, Vitetta ES . A phase I study of an anti-CD22-deglycosylated ricin a chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 1993; 82: 2624–2633.
4. Sausville E, Headlee D, Stetler-Stevenson M, Jaffe E, Solomon D, Figg W, Herdt J, Kopp W, Rager H, Steinberg S, Ghetie V, Schindler J, Uhr JW, Wittes RE, Vitetta ES . Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. Blood 1995; 85: 3457–3465.
5. Messmann R, Vitetta ES, Headlee D, Senderowicz A, Figg W, Schindler J, Michiel D, Creekmore S, Steinberg S, Kohler D, Jaffe E, Stetler-Stevenson M, Chen H, Ghetie V, Sausville E . A phase I study of combination therapy with immunotoxins IgG-HD37-dgA and IgG-RFB4-dgA (combotox) in patients with refractory CD19(+), CD22(+) B-cell lymphoma. Clin Cancer Res 2000; 6: 1302–1313.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献